Fig. 2From: Emerging hallmark of gliomas microenvironment in evading immunity: a basic conceptMechanism of CAR T-cell therapy. The figure shows an illustration of combining CAR T-cell therapy with oncolytic viruses or immune checkpoint inhibitors resulted enhanced therapeutic outcomes for gliomas. (Original figure: created by co-author of this article for this article)Back to article page